Finance

Lists
CCEL:NYSEAMERICAN
Cryo-Cell International Inc
3,91 USD
+0,77%
(+0,030) 1D
7-окт., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CCEL...
Open
3,90 USD
High
3,93 USD
Low
3,90 USD
Mkt. cap
31,52 млн
Avg. vol.
12,13 миң
Volume
0,00
52-wk high
4,90 USD
52-wk low
2,72 USD
EPS
-0,31 USD
Beta
0,08
Shares outstanding
8,06 млн
No. of employees
74
Open
3,90 USD
High
3,93 USD
Low
3,90 USD
Mkt. cap
31,52 млн
Avg. vol.
12,13 миң
Volume
0,00
52-wk high
4,90 USD
52-wk low
2,72 USD
EPS
-0,31 USD
Beta
0,08
Shares outstanding
8,06 млн
No. of employees
74
News stories
From web sources and news partners
Bloomberg Government News
Bloomberg Government News
·
45 мүнөт мурун
Nasdaq-Listed Lobbying Firm Launches Capitol Hill Oversight Unit
www.marketscreener.com
www.marketscreener.com
·
46 мүнөт мурун
Kyivstar to Report 3Q26 Results on November 6, 2026
Yahoo Finance
Yahoo Finance
·
1 саат мурун
Prediction: The S&P 500 Will Hit 10,000 in 2027
Profile
Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL. Wikipedia
About Cryo-Cell International Inc
CEOMark L. Portnoy | David I. Portnoy
Employees74
Founded1989
HeadquartersОлдсмар, Флорида, Америка Кошмо Штаттары
SectorHealth care provider
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. авг.
2025-ж. ноя.
2026-ж. фев.
2026-ж. май
Revenue
7,83 млн
7,84 млн
7,68 млн
7,78 млн
Cost of goods sold
1,80 млн
6,09 млн
1,66 млн
1,68 млн
Cost of revenue
1,80 млн
6,09 млн
1,66 млн
1,68 млн
Research and development expenses
61,62 миң
84,78 миң
65,76 миң
99,78 миң
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,88 млн
5,45 млн
5,01 млн
4,62 млн
Operating expense
4,12 млн
5,72 млн
5,26 млн
4,90 млн
Total operating expenses
5,92 млн
11,81 млн
6,92 млн
6,58 млн
Operating income
1,90 млн
-3,97 млн
765,13 миң
1,20 млн
Other non operating income
17,56 миң
18,41 миң
8,34 миң
338,00
EBT including unusual items
1,19 млн
-4,63 млн
70,31 миң
827,78 миң
EBT excluding unusual items
1,38 млн
-4,43 млн
310,77 миң
755,76 миң
Income tax expense
436,59 миң
-814,54 миң
23,20 миң
273,20 миң
Effective tax rate
36,81%
17,59%
33,00%
33,00%
Other operating expenses
-
-
-
-
Net income
749,41 миң
-3,82 млн
47,11 миң
554,59 миң
Net profit margin
9,58%
-48,67%
0,61%
7,13%
Earnings per share
0,10
-0,47
0,02
0,07
Interest and investment income
-
-
-
-
Interest expense
-538,22 миң
-481,95 миң
-462,71 миң
-441,92 миң
Net interest expenses
-538,22 миң
-481,95 миң
-462,71 миң
-441,92 миң
Depreciation and amortization charges
185,69 миң
183,83 миң
183,89 миң
184,33 миң
EBITDA
2,14 млн
-3,72 млн
1,01 млн
1,44 млн
Gain or loss from assets sale
633,00
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору